- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05224219
Modified Preloaded System for Renal Arteries in Fenestrated Endografting (MPSRA) (MPSRA)
Modified Preloaded System for Renal Arteries in Fenestrated Endografting
Study Overview
Status
Detailed Description
Thoracoabdominal aortic aneurysm (TAAA) and complex abdominal aortic aneurysms (AAA) represents an evolving pathology that involves to varying degrees both the descending thoracic aorta and the abdominal aorta. These aneurysms, according to their localization and involvement in the thoracic and abdominal aorta, have been classified according to Crawford into 4 groups (I-IV) for the TAAA and in pararenal/juxtarenal (p/j-AAA) for AAA when a standard endovascular repair is not possible.
The prevalence of these pathologies is currently not well known, but high mortality rates are reported in the population carrying TAAAs and j/p-AAAs that have not undergone surgical treatment, most of which are due to aortic rupture.
Among of the main complications related to TAAA endovascular repair and to complex AAA we can account spinal cord ischemia, lower leg ischemia and logo-operative times, that all can contribute to decrease overall technical and clinical success.
A particular subgroup of TAAAs is represented by post-dissection thoracoabdominal aneurysms (PDTAA), which represents an evolving pathology and one of the main chronic complications in outcomes of acute chronic dissection. In these particular subset of patients, as well as in patient with highly calcified and hostile accesses, the risk of post-operative spinal cord ischemia is higher and the availability of both iliac access navigability is not always possible, leading to technical failure, intraoperative complications and need for adjunctive invasive procedures in high surgical risk patients.
The fenestrated and branched endoprostheses (F/B-EVAR) represent a technology that is now firmly used for the treatment of thoraco-abdominal degenerative aneurysmal pathology in superspecialized centers. Recently, the technology with F/B-EVAR has also been used in the treatment of PDTAA, IMH and PAU, showing satisfactory results. This experience has been carried out in some centers, in the absence, however, of a wider and generalized experience. All these type of endografts are custom-made devices, requiring therefore a lading time for production and delivering before being implanted into the specific patient.
In order to overcome main drawbacks of these procedures, such us long operating time due to fenestrations and vessels cannulation, to avoid bilateral lower limbs ischemia due to large bore introducer sheaths and to accomplish successful delivery even in patient without navigability of both iliac accesses, a modified preloaded system for renal arteries has been developed by Cook (Cook Medical, Bloomington, IN, USA).
The aim of the study is to evaluate in a prospective single center study observational setting, the outcomes, safety and efficacy of the modified preloaded system for renal arteries developed by Cook Medical with bi-port handle system in the field of fenestrated endografting during the routine treatment of thoraco-abdominal and paravisceral abdominal aortic pathologies.
Study Type
Enrollment (Anticipated)
Contacts and Locations
Study Contact
- Name: Enrico Gallitto, MD, PhD
- Phone Number: +393330512143288
- Email: enrico.gallitto@gmail.com
Study Locations
-
-
Emilia Romagna
-
Bologna, Emilia Romagna, Italy, 40138
- Recruiting
- University of Bologna
-
Contact:
- Enrico Gallitto, MD, PhD
- Phone Number: +390512143288
- Email: enrico.gallitto@gmail.com
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Diagnosis of thoraco-abdominal or complex abdominal aortic aneurysm confirmed by a Computed tomography Angiography (CTA).
- Etiologies will be degenerative aneurysms, inflammatory aneurysms, chronic post-dissectional aneurysms, penetrating aortic ulcers, failure of prior surgical or endovascular repair.
- Elective aneurysmal repair of patient with maximum diameter greater than 55 mm, or fast growing, or symptomatic aneurysms.
- Endovascular repair performed using custom-made fenestrated and/or branched endografting with presence of modified preloaded system with modified handle and preloaded catheters for visceral vessels cannulation.
Exclusion Criteria:
- Patients submitted to advanced fenestrated and branched endovascular repair with other grafts besides the Cook Medical custom-made endograft or without modified handle preloaded delivery system.
- Physician-modified devices
- Patient treated with hybrid and/or open technique as well as parallel grafts (such as chimney/snorkel/periscope)
- Patient treated as emergent/urgent patients or aneurysmal rupture
- Patient who can not wait for the lead time required for endograft production and delivery.
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Technical Success
Time Frame: Intra-operative final completion angiography.
|
Successful deployment of custom-made modified endograft, target vessel patency and aneurysm exclusion, in absence of intra-operative mortality.
|
Intra-operative final completion angiography.
|
Mortality
Time Frame: Within the first 30-days from the procedure.
|
Assessment of mortality related to procedure
|
Within the first 30-days from the procedure.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Cardiovascular Adverse Events
Time Frame: Within the first 30-days from the procedure.
|
Cardiopulmonary and renal events related to the procedure.
|
Within the first 30-days from the procedure.
|
Neurologic Adverse Events
Time Frame: Within the first 30-days from the procedure.
|
Incidence of Spinal Cord Ischemia (transient/permanent) and Stroke
|
Within the first 30-days from the procedure.
|
Vessel Instability
Time Frame: Within the first 30-days from the procedure.
|
Target vessel patency and absence of stenosis, endoleak, occlusion, need for reintervention
|
Within the first 30-days from the procedure.
|
Rate of early reintervention
Time Frame: Within the first 30-days from the procedure.
|
Any re-intervention needed after the type of procedure and the specific reason
|
Within the first 30-days from the procedure.
|
Overall Survival
Time Frame: Through study completion, an average of 1 year.
|
Assessment of mortality in the post-operative period
|
Through study completion, an average of 1 year.
|
Aorta Related Survival
Time Frame: Through study completion, an average of 1 year.
|
Assessment of mortality in the post-operative period related to aortic procedure or aortic related death.
|
Through study completion, an average of 1 year.
|
Freedom from reintervention
Time Frame: Through study completion, an average of 1 year.
|
Time from procedure to the first aortic related/procedure related reintervention
|
Through study completion, an average of 1 year.
|
Freedom from Vessel Instability
Time Frame: Through study completion, an average of 1 year.
|
Target vessel patency and absence of stenosis, endoleak, occlusion, need for reintervention
|
Through study completion, an average of 1 year.
|
Freedom from Major Endoleaks
Time Frame: Through study completion, an average of 1 year.
|
Time from procedure to the presence of high-flow endoleak (TypeI/III) and from endoleak that required reintervention
|
Through study completion, an average of 1 year.
|
Collaborators and Investigators
Sponsor
Publications and helpful links
General Publications
- Gallitto E, Faggioli G, Spath P, Pini R, Mascoli C, Ancetti S, Stella A, Abualhin M, Gargiulo M. The risk of aneurysm rupture and target visceral vessel occlusion during the lead period of custom-made fenestrated/branched endograft. J Vasc Surg. 2020 Jul;72(1):16-24. doi: 10.1016/j.jvs.2019.08.273. Epub 2020 Feb 13.
- Gallitto E, Gargiulo M, Faggioli G, Pini R, Mascoli C, Freyrie A, Ancetti S, Stella A. Impact of iliac artery anatomy on the outcome of fenestrated and branched endovascular aortic repair. J Vasc Surg. 2017 Dec;66(6):1659-1667. doi: 10.1016/j.jvs.2017.04.063. Epub 2017 Sep 6.
- Maurel B, Resch T, Spear R, Roeder B, Bracale UM, Haulon S, Mastracci TM. Early experience with a modified preloaded system for fenestrated endovascular aortic repair. J Vasc Surg. 2017 Apr;65(4):972-980. doi: 10.1016/j.jvs.2016.09.045.
- Spanos K, Kolbel T, Kubitz JC, Wipper S, Konstantinou N, Heidemann F, Rohlffs F, Debus SE, Tsilimparis N. Risk of spinal cord ischemia after fenestrated or branched endovascular repair of complex aortic aneurysms. J Vasc Surg. 2019 Feb;69(2):357-366. doi: 10.1016/j.jvs.2018.05.216. Epub 2018 Oct 29.
- Bertoglio L, Loschi D, Grandi A, Melloni A, Bilman V, Melissano G, Chiesa R. Early Limb Reperfusion Using Routinely Preloaded Fenestrated Stent-graft Designs for Complex Endovascular Aortic Procedures. Cardiovasc Intervent Radiol. 2020 Dec;43(12):1868-1880. doi: 10.1007/s00270-020-02596-1. Epub 2020 Jul 19.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- MPSRA
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Juxtarenal Aortic Aneurysm
-
Assiut UniversityUnknownJuxtarenal Aortic Aneurysm
-
EndologixCompletedJuxtarenal Aortic Aneurysm | Pararenal Aortic AneurysmNew Zealand, Chile
-
University of California, San DiegoRecruitingJuxtarenal Aortic Aneurysm | Thoracoabdominal Aortic Aneurysm | Pararenal Aortic Aneurysm | Complex Abdominal Aortic AneurysmUnited States
-
Clinical Centre of SerbiaIRCCS Azienda Ospedaliero-Universitaria di Bologna; Helsinki University Central... and other collaboratorsUnknownJuxtarenal Aortic Aneurysm | Pararenal AneurysmSerbia
-
Hangzhou Endonom Medtech Co., Ltd.RecruitingJuxtarenal Abdominal Aortic AneurysmChina
-
Cook Research IncorporatedRecruitingAortic Aneurysm, Abdominal | Juxtarenal Aortic Aneurysm | Extent IV Thoracoabdominal | Pararenal AneurysmUnited States
-
Medical University of ViennaActive, not recruitingRenal Function Disorder | Aortic Aneurysm | Juxtarenal Aortic AneurysmAustria
-
Cook Group IncorporatedApproved for marketingAbdominal Aortic Aneurysms | Aorto-iliac Aneurysms | Juxtarenal AneurysmsUnited States
-
Cook Research IncorporatedCompletedAbdominal Aortic Aneurysm (AAA) | Aorto-iliac Aneurysm | Juxtarenal AneurysmUnited States
-
Augusta Hospital DuesseldorfTel Aviv University; Storz GmbH FRGWithdrawnInfra and Juxtarenal Abdominal Aortic Aneurysms